Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.64 |
| ▸ | ALPI | P09923 | 1/20 | 0.59 |
| ▸ | PKM | P14618 | 1/20 | 0.59 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.59 |
| ▸ | XIAP | P98170 | 1/20 | 0.59 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.59 |
| ▸ | KDM6B | O15054 | 1/20 | 0.57 |
| ▸ | CPA1 | P15085 | 4/20 | 0.55 |
| ▸ | CPA3 | P15088 | 3/20 | 0.55 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.55 |
| ▸ | CPB1 | P15086 | 1/20 | 0.55 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.55 |
| ▸ | PTPRA | P18433 | 1/20 | 0.55 |
| ▸ | SRR | Q9GZT4 | 2/20 | 0.53 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.53 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.53 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.53 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL57558 | 1.00 | CYP1A2 (0.64) | CYP1A2ALPIPKMPTGS1XIAP | |
| SCHEMBL8953468 | 1.00 | CYP1A2 (0.64) | CYP1A2ALPIPKMPTGS1XIAP | |
| SCHEMBL197252 | 1.00 | CYP1A2 (0.64) | CYP1A2ALPIPKMPTGS1XIAP | |
| Hydrochloric Acid SCHEMBL1374834 | 0.98 | CYP1A2 (0.61) | CYP1A2ALPIPKMPTGS1XIAP | |
| Methane SCHEMBL3799102 | 0.98 | CYP1A2 (0.61) | CYP1A2ALPIPKMPTGS1XIAP | |
| SCHEMBL5800210 | 0.98 | CYP1A2 (0.61) | CYP1A2ALPIPKMPTGS1XIAP | |
| Hydrochloric Acid SCHEMBL1374832 | 0.98 | CYP1A2 (0.61) | CYP1A2ALPIPKMPTGS1XIAP | |
| Acetone SCHEMBL16013120 | 0.94 | ALPI (0.59) | CYP1A2ALPIPKMPTGS1XIAP | |
| SCHEMBL22767830 | 0.92 | CYP1A2 (0.55) | CYP1A2ALPIPKMPTGS1XIAP | |
| Tetramethylammonium Ion SCHEMBL9303721 | 0.92 | CYP1A2 (0.55) | CYP1A2ALPIPKMPTGS1XIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 571 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| CN-120114342-A | Use of 3-phenyllactate or a fermentation product comprising 3-phenyllactate for the preparation of a skin care product and a skin care product | 山东萨科睿德生物技术有限公司 | 2025-06-10 | — | — | CN | claimed |
| CN-119798135-A | Organic compound, preparation method thereof, bactericide and purifying device | 珠海格力电器股份有限公司 | 2025-04-11 | — | — | CN | claimed |
| WO-2024167565-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | PURDUE RESEARCH FOUNDATION (US) | 2024-08-15 | — | — | WO | claimed |
| CN-117567425-A | Method for preparing cyclic carbonate from halogen-free ionic liquid | 南京工业大学 | 2024-02-20 | — | — | CN | claimed |
| CN-117417513-A | Method for preparing polyester by catalyzing ring-opening polymerization of cyclic monomer based on acid-base adduct of organic alkali and alpha-hydroxy acid | 南京工业大学 | 2024-01-19 | — | — | CN | claimed |
| US-20230405091-A1 | METHODS OF MODULATING GASTROINTESTINAL METABOLITES | DSM IP ASSETS B.V. (NL) | 2023-12-21 | — | — | US | claimed |
| EP-4228424-A1 | METHODS OF MODULATING GASTROINTESTINAL METABOLITES | DSM IP Assets B.V. (NL) | 2023-08-23 | — | — | EP | claimed |
| US-20230200412-A1 | METHODS OF MODULATING GASTROINTESTINAL MICROBIAL METABOLIC PATHWAYS AND METABOLITES | DSM IP ASSETS B.V. (NL) | 2023-06-29 | — | — | US | claimed |
| EP-4118090-A1 | METHODS OF MODULATING GASTROINTESTINAL MICROBIAL METABOLIC PATHWAYS AND METABOLITES | DSM IP Assets B.V. (NL) | 2023-01-18 | — | — | EP | claimed |
| WO-2010118241-A2 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES | INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION (US) | 2010-10-14 | — | — | WO | claimed |
| US-7811804-B2 | synthetic or recombinant polypeptide having a nitrilase activity; have increased activity and stability at increased pH and temperature | VERENIUM CORPORATION (US) | 2010-10-12 | — | — | US | claimed |
| US-20100216214-A1 | hydrolysis of a hydroxyglutaryl nitrile to generate an ethyl 4-cyano-3-hydroxybutyrate; hydrolysis of a mandelonitrile to generate a mandelic acid; hydrolysis of phenyllactocyanonitrile to generate an (S)-phenyllactic acid | VERENIUM CORPORATION (US) | 2010-08-26 | — | — | US | claimed |
| EP-2115153-A2 | NITRILASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM | Verenium Corporation (US) | 2009-11-11 | — | — | EP | claimed |
| US-7521216-B2 | Nitrilases and methods for making and using them | VERENIUM CORPORATION (US) | 2009-04-21 | — | — | US | claimed |
| EP-2039762-A2 | Nitralases | Verenium Corporation (US) | 2009-03-25 | — | — | EP | claimed |
| WO-2008106662-A2 | NITRILASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM | VERENIUM CORPORATION (US) | 2008-09-04 | — | — | WO | claimed |
| US-20040014195-A1 | Nitrilases, nucleic acids encoding them and methods for making and using them | DIVERSA CORPORATION (US) | 2004-01-22 | — | — | US | claimed |
| US-20040002147-A1 | Nitrilases | DIVERSA CORPORATION | 2004-01-01 | — | — | US | claimed |
| US-20030124698-A1 | Which stereoselectively hydrolyze nitrites or cyanohydrins into acids and ammonia | DIVERSA CORPORATION | 2003-07-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040014195-A1 | Nitrilases, nucleic acids encoding them and methods for making and using them | RNGTT, NSUN2, NSUN3 | CYP1A2 2975/4885ALPI 3189/4885PKM 3644/4885 |
| US-20040002147-A1 | Nitrilases | RNGTT, DNTT, NOP2 | CYP1A2 1608/4885ALPI 2707/4885PKM 3118/4885 |
| US-20030124698-A1 | Which stereoselectively hydrolyze nitrites or cyanohydrins into acids and ammonia | NIT2, DNPH1, ASNS | CYP1A2 1283/4885ALPI 1278/4885PKM 3109/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.